Clinical Trial Update: Modulation of Human Myocardial Metabolism by GLP-1 Dose Response [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update summarizes Phase 2/3 results on GLP-1 modulation of human myocardial metabolism in adults with type 2 diabetes and in healthy volunte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GLP-1 (glucagon-like peptide-1)

Snippet

Sponsor: Indiana University | Conditions: Type 2 Diabetes Mellitus, Healthy | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-02-17